Search Results 191-200 of 18469 for Crohns disease

1. Pediatric MSC-AFP Sub-study for Crohn's Fistula - Mayo Clinic

   Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

2. Patients with Inflammatory Bowel Disease (IBD) are at Increased Risk for Colorectal Cancer and Early Dysplasia - Mayo Clinic

   Map and compare the neoplasia-associated epigenetic field in IBD-CRN, sporadic CRN and controls. Measure sensitivity of DNA methylation for the detection of ...

3. infant sleep recommendations Archives - Mayo Clinic News Network

   Crohn's disease, an inflammatory bowel disease that most often begins gradually but can worsen over time. Symptoms can include diarrhea, abdominal pain and ...

4. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease - Mayo Clinic

   ... during induction and maintenance treatment of moderately to severely active Crohn's disease (CD) in participants who are biologic-naive and biologic-experienced ...

5. An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease - Mayo Clinic

   This is an investigational study, also known as LATTICE-CD, of the experimental medication BMS-986165 in participants with moderate to severe Crohn's Disease, a ...

6. Infliximab-abda (intravenous route) - Mayo Clinic

   ... and chronic severe plaque psoriasis. It is used in children to treat Crohn's disease and ulcerative colitis. Infliximab-abda injection is a monoclonal ...

7. Comparing modalities for detecting dysplasia in patients with IBD - Mayo Clinic

   People with inflammatory bowel disease (IBD), such as Crohn's disease and ulcerative colitis, are at increased risk of developing colorectal cancer compared ...

8. An Extension Study of Oral Ozanimod for Moderately-to-Severely Active Crohn's Disease - Mayo Clinic

   The purpose of this extension study is to evaluate the safety and effectiveness of ozanimod in subjects with moderately to severely active Crohn's Disease.

9. A Study to Test the Safety and Effectiveness of PF-00547659 for Patients who have Crohn's Disease - Mayo Clinic

   The purpose of this study is to assess the safety and effectiveness of PF-00547659 (experimental drug) for patients who have Crohn's disease that is clinically ...

10. Crohn's disease - Doctors and departments - Mayo Clinic

    Mayo Clinic researchers are working to improve diagnosis and treatment of Crohn's disease. Radiologists at Mayo Clinic were instrumental in developing novel ...